Προωθημένο
Breakthrough Gene & Immunotherapies Propel Global GBM Market Growth
 Glioblastoma Multiforme Market Poised to Reach USD 4.5 Billion by 2031, Driven by R&D Surge and Rising Disease Burden in the US and Japan The Global Glioblastoma Multiforme (GBM) Market reached USD 2.4 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 4.5 billion by 2031. The market is expected to exhibit a compound annual growth rate (CAGR) of 8.6%...
0 Σχόλια 0 Μοιράστηκε 34 Views 0 Προεπισκόπηση
Προωθημένο
Προωθημένο
Προωθημένο